Pesquisar
Fresenius Medical Care AG
FMSAdicionar à lista de desejos
21.390USD
-0.850-3.82%
Fechamento 05/13, 16:00（ET）Cotações atrasadas em 15 min
12.55BValor de mercado
11.42P/L TTM
Mais detalhes de Fresenius Medical Care AG Empresa
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Informações de Fresenius Medical Care AG
Código da empresaFMS
Nome da EmpresaFresenius Medical Care AG
Data de listagemOct 02, 1996
CEOCordola (Craig)
Número de funcionários111513
Tipo de títulosDepository Receipt
Fim do ano fiscalOct 02
EndereçoElse-Kroener-Strasse 1
CidadeBAD HOMBURG VOR DER HOHE
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísGermany
Código postal61352
Telefone4961726090
Sitehttps://www.freseniusmedicalcare.com/
Código da empresaFMS
Data de listagemOct 02, 1996
CEOCordola (Craig)
Executivos da empresa Fresenius Medical Care AG
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Martin Fischer
Mr. Martin Fischer
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Mr. Michael Sen
Mr. Michael Sen
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--
Mr. Shervin J. Korangy
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
North America
15.99B
72.25%
Rest of the world
5.58B
25.23%
Germany
557.65M
2.52%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: há 46 minutos
Atualizado em: há 46 minutos
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Pzena Investment Management, LLC
2.79%
Wellington Management Company, LLP
1.52%
Fiduciary Management, Inc.
0.92%
Dodge & Cox
0.71%
Todd Asset Management LLC
0.24%
Outro
93.83%
Investidores
Investidores
Proporção
Pzena Investment Management, LLC
2.79%
Wellington Management Company, LLP
1.52%
Fiduciary Management, Inc.
0.92%
Dodge & Cox
0.71%
Todd Asset Management LLC
0.24%
Outro
93.83%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
5.56%
Investment Advisor
2.23%
Hedge Fund
0.50%
Research Firm
0.49%
Pension Fund
0.15%
Family Office
0.02%
Venture Capital
0.02%
Bank and Trust
0.02%
Outro
91.01%
Participação acionária institucional
Atualizado em: dom, 5 de abr
Atualizado em: dom, 5 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
372
48.53M
8.98%
+134.66K
2025Q4
329
47.00M
8.10%
--
2025Q3
337
47.00M
8.12%
-7.47K
2025Q2
350
47.02M
8.22%
+2.00M
2025Q1
348
45.04M
8.08%
-2.40M
2024Q4
337
43.94M
8.01%
+456.34K
2024Q3
325
43.49M
7.70%
+2.26M
2024Q2
343
41.23M
8.48%
-1.66M
2024Q1
362
42.90M
8.31%
-5.86M
2023Q4
362
42.80M
8.39%
+76.36K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Pzena Investment Management, LLC
14.75M
2.64%
-64.02K
-0.43%
Dec 31, 2025
Wellington Management Company, LLP
8.20M
1.47%
--
--
Dec 31, 2025
Fiduciary Management, Inc.
4.96M
0.89%
-495.42K
-9.08%
Dec 31, 2025
Dodge & Cox
3.83M
0.69%
--
--
Dec 31, 2025
Todd Asset Management LLC
1.29M
0.23%
-16.66K
-1.28%
Dec 31, 2025
Aristotle Capital Management, LLC
1.13M
0.2%
--
--
Dec 31, 2025
Point72 Asset Management, L.P.
1.13M
0.2%
+598.81K
+112.14%
Dec 31, 2025
Morgan Stanley & Co. LLC
984.84K
0.18%
+971.72K
+7405.82%
Dec 31, 2025
Morgan Stanley & Co. International Plc
958.00K
0.17%
+50.00K
+5.51%
Dec 31, 2025
Parametric Portfolio Associates LLC
942.19K
0.17%
-42.81K
-4.35%
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Cultivar ETF
1.01%
ActivePassive International Equity ETF
0.08%
Avantis Responsible International Equity ETF
0.06%
Avantis International Equity ETF
0.01%
Pacer Developed Markets International Cash Cws 100
0%
Unusual Whales Subversive Democratic Trading ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
SGI Enhanced Global Income ETF
0%
Unusual Whales Subversive Republican Trading ETF
0%
The Opal International Dividend Income ETF
0%
Ver Mais
Cultivar ETF
Proporção1.01%
ActivePassive International Equity ETF
Proporção0.08%
Avantis Responsible International Equity ETF
Proporção0.06%
Avantis International Equity ETF
Proporção0.01%
Pacer Developed Markets International Cash Cws 100
Proporção0%
Unusual Whales Subversive Democratic Trading ETF
Proporção0%
DFA Dimensional International Core Equity 2 ETF
Proporção0%
SGI Enhanced Global Income ETF
Proporção0%
Unusual Whales Subversive Republican Trading ETF
Proporção0%
The Opal International Dividend Income ETF
Proporção0%
Dividendo
Um total de
1.59B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
May 01, 2026
FMS.NB Approximate final Cash Dividend of gross USD 0.871575 paid on Jun 08, 2026 going ex on May 22, 2026
May 22, 2026
Jun 08, 2026
May 22, 2026
May 07, 2025
FMS.NB Final Cash Dividend of gross USD 0.814968 paid on Jun 06, 2025 going ex on May 23, 2025
May 23, 2025
Jun 06, 2025
May 23, 2025
Apr 15, 2024
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
May 20, 2024
Jun 03, 2024
May 17, 2024
May 03, 2023
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
May 18, 2023
Jun 01, 2023
May 17, 2023
Apr 28, 2022
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
May 16, 2022
May 27, 2022
May 13, 2022
May 16, 2021
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
May 25, 2021
Jun 07, 2021
May 24, 2021
Aug 12, 2020
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020
Aug 31, 2020
Sep 11, 2020
Aug 28, 2020
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
